Here's why Fortescue Metals Group Limited slipped 5.6%

Fortescue Metals Group Limited (ASX:FMG) has returned to the red after a more positive day on Thursday.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of iron ore giant Fortescue Metals Group Limited (ASX: FMG) have resumed their position in the red on Friday, more than reversing Thursday's gain of more than 5%.

So What: Fortescue's shareholders were given a brief sense of relief last Thursday after the miner delivered its March quarterly production report, revealing lower-than-expected costs and an additional US$200 million on its cash balance. Additionally, the iron ore price rebounded above US$50 a tonne, leading investors to believe a rebound was possible for the commodity.

Unfortunately, the jump in iron ore prices looks as though it could just be temporary with the commodity once again slipping below US$50 a tonne overnight, according to the Metal Bulletin. As Chinese demand growth slows and the world's largest producers (including Fortescue) continue to ramp up their production rates, it's likely that the commodity will slip further.

In fact, Goldman Sachs estimates that prices will average roughly US$44 a tonne in 2016, and US$40 a tonne in 2017. The government and Citigroup are even more bearish on the commodity, suggesting that prices of US$35 a tonne and US$37 a tonne are possible this year, respectively.

Now What: Although Fortescue's results may have been better than what the market had been expecting, the fact remains that it is a mining company left completely at the mercy of the iron ore price itself. Should iron ore continue to fall, it will only impact Fortescue's earnings further and make it increasingly difficult to repay its debts and to generate sufficient shareholder returns.

Investors left holding the stock may want to consider selling, or at very least limiting their exposure in the event that prices do fall further.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »